Based in USA, Polymed Therapeutics has been at the forefront in the manufacture of APIs and Chemicals, with state-of-the-art and regulatory approved cGMP facilities and R&D laboratories in China.
For the past decade our API division has been a leader in the supply of pharmaceutical grade yet low cost specialty active ingredients and intermediates, for the global market. Our product portfolio has since expanded from Paclitaxel to more oncology APIs, Vitamin D analogues, plus other categories.
Our Fine Chemicals division specializes in Custom Synthesis, and serves the global markets of Pharmaceutical and Specialty Chemicals. Our team of scientists is expert in the whole range of manufacture - from R&D, pilot scale, to industrial scale. Being flexible and fast, our plants achieve extremely complex or simple synthesis, for large or small demands.
Our in-vitro diagnostic devices are rapid testing kits used to detect, prevent, and diagnose various medical conditions. These kits are simple to use and are priced competitively to meet our customers' needs. Our scientific team of experts manufacture these high quality medical device kits. Polymed is a cGMP facility that meets the ISO standards.
Polymed is financially stable, technologically proficient and dedicated to providing the most excellent products and services at competitive costs, to be the optimal strategic supplier to global customers.
To be the leading strategic API supplier to global customers.
Constantly improving to provide the best value to our customers, by making the highest quality products at the most competitive cost, whilst strictly adhering to pharmaceutical, safety, health and environmental regulations.